
|Videos|December 10, 2014
Impact of Provider Status on Health-System Pharmacists
Joseph Hill, MA, director of federal legislative affairs for ASHP, explains how provider status would impact health-system pharmacists' daily practice.
Advertisement
Joseph Hill, MA, director of federal legislative affairs for ASHP, explains how provider status would impact health-system pharmacists' daily practice.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
2
Integrating Combination Therapies for Type 2 Diabetes and CKD
3
SGLT2 Inhibitors Linked to Lower Atrial Fibrillation Risk, Recurrence
4
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
5












































































































































































































